ResearcherHarvard UniversityActive in the last 2 years

Richard D Cummings

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8918-5034; OpenAlex author ID A5023341393; NIH RePORTER profile ID 1884718. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 1
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 2 papers · 2026: 1 grant

Papers 2

Differential expression of CD175 and CA19-9 in pancreatic adenocarcinoma. Last author DOI 10.1038/s41598-025-86988-8 ↗
Unraveling the glyco-immunity nexus in pancreatic cancer. First author DOI 10.1186/s12943-025-02417-4 ↗

Grants 1

Targeting Disease Specific Tn Antigen in Pancreatic Cancer R01CA288372 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Prakash Radhakrishnan · 1 shared paper, 1 shared grant, 2025–2026 · strength 1.69
- Grant Targeting Disease Specific Tn Antigen in Pancreatic Cancer R01CA288372 ↗
- Paper Unraveling the glyco-immunity nexus in pancreatic cancer. DOI 10.1186/s12943-025-02417-4 ↗
Christabelle Rajesh · 1 shared paper, 2025 · strength 0.42
- Paper Unraveling the glyco-immunity nexus in pancreatic cancer. DOI 10.1186/s12943-025-02417-4 ↗
Jane J. Cheng · 1 shared paper, 2025 · strength 0.27
- Paper Differential expression of CD175 and CA19-9 in pancreatic adenocarcinoma. DOI 10.1038/s41598-025-86988-8 ↗
Kathryn A. Stackhouse · 1 shared paper, 2025 · strength 0.27
- Paper Differential expression of CD175 and CA19-9 in pancreatic adenocarcinoma. DOI 10.1038/s41598-025-86988-8 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.